Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 13, 2020
[Systemic drug treatment during pregnancy]Maximilian Riedel, Bettina Kuschel
Expert Review of Molecular Diagnostics|May 5, 2021
The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancerMaximilian Riedel, Holger Bronger, Viktor Magdolen, et al.
Data in Brief|June 29, 2023
Solar spectra datasets at optimum and vertical installation angles in central Europe (Berlin) during 2020, 2021 and 2022Guillermo A Farias-Basulto, Maximilian Riedel, Mark Khenkin, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 14, 2025
AI-driven simplification of surgical reports in gynecologic oncology: A potential tool for patient educationMaximilian Riedel, Bastian Meyer, Raphael Kfuri Rubens, et al.
British Journal of Cancer|June 27, 2025
PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancerChristoph Stange, Tobias F Dreyer, Maximilian Riedel, et al.
Journal of Laser Applications|April 16, 2019
Femtosecond Laser Eyewear Protection: Measurements and Precautions for Amplified High Power ApplicationsMaximilian Riedel-Topper, Sarah Wirick, Joshua A Hadler, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|June 13, 2025
Exploring the potential of AI-powered applications for clinical decision-making in gynecologic oncologyBastian Meyer, Raphael Kfuri-Rubens, Georg Schmidt, et al.
The Journal of Physical Chemistry. B|July 24, 2019
Photodynamics of [FeFe]-Hydrogenase Model Compounds with Bidentate Heterocyclic LigandsWyatt Thornley, Sarah A Wirick, Maximilian Riedel-Topper, et al.
BMC Cancer|January 29, 2025
The implementation and side effect management of immune checkpoint inhibitors in gynecologic oncology: a JAGO/NOGGO surveyMaximilian Riedel, Helene Herrmann, Thomas Bartl, et al.
Pageof 2